1178 related articles for article (PubMed ID: 11156411)
1. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
[TBL] [Abstract][Full Text] [Related]
2. [An approach to early genetic alterations in precancerous cells].
Sato N; Nishida M; Noguchi M
Hum Cell; 2000 Sep; 13(3):103-8. PubMed ID: 11197771
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.
Lin WM; Forgacs E; Warshal DP; Yeh IT; Martin JS; Ashfaq R; Muller CY
Clin Cancer Res; 1998 Nov; 4(11):2577-83. PubMed ID: 9829719
[TBL] [Abstract][Full Text] [Related]
4. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.
Obata K; Morland SJ; Watson RH; Hitchcock A; Chenevix-Trench G; Thomas EJ; Campbell IG
Cancer Res; 1998 May; 58(10):2095-7. PubMed ID: 9605750
[TBL] [Abstract][Full Text] [Related]
5. Common genetic changes between endometriosis and ovarian cancer.
Obata K; Hoshiai H
Gynecol Obstet Invest; 2000; 50 Suppl 1():39-43. PubMed ID: 11093060
[TBL] [Abstract][Full Text] [Related]
6. [Pathogenic role of PTEN tumor suppressor gene in ovarian cancer associated to endometriosis].
Castiblanco G A; Pires N Y; Wistuba O I; Riquelme S E; Andrade M L; Corvalán R A
Rev Med Chil; 2006 Mar; 134(3):271-8. PubMed ID: 16676097
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas.
Catasús L; Bussaglia E; Rodrguez I; Gallardo A; Pons C; Irving JA; Prat J
Hum Pathol; 2004 Nov; 35(11):1360-8. PubMed ID: 15668893
[TBL] [Abstract][Full Text] [Related]
8. PTEN as a molecular marker to distinguish metastatic from primary synchronous endometrioid carcinomas of the ovary and uterus.
Ricci R; Komminoth P; Bannwart F; Torhorst J; Wight E; Heitz PU; Caduff RF
Diagn Mol Pathol; 2003 Jun; 12(2):71-8. PubMed ID: 12766611
[TBL] [Abstract][Full Text] [Related]
9. Possible involvement of loss of heterozygosity in malignant transformation of ovarian endometriosis.
Xu B; Hamada S; Kusuki I; Itoh R; Kitawaki J
Gynecol Oncol; 2011 Feb; 120(2):239-46. PubMed ID: 21130491
[TBL] [Abstract][Full Text] [Related]
10. Genetics of synchronous uterine and ovarian endometrioid carcinoma: combined analyses of loss of heterozygosity, PTEN mutation, and microsatellite instability.
Fujii H; Matsumoto T; Yoshida M; Furugen Y; Takagaki T; Iwabuchi K; Nakata Y; Takagi Y; Moriya T; Ohtsuji N; Ohtsuji M; Hirose S; Shirai T
Hum Pathol; 2002 Apr; 33(4):421-8. PubMed ID: 12055677
[TBL] [Abstract][Full Text] [Related]
11. [Genetic analysis of endometriosis and ovarian cancer].
Obata K; Hoshiai H
Nihon Rinsho; 2001 Jan; 59 Suppl 1():217-20. PubMed ID: 11235170
[No Abstract] [Full Text] [Related]
12. Correspondence re: W.M. Lin et al., loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas. Clin. Cancer Res., 4: 2577-2583, 1998.
Matias-Guiu X; Bussaglia E; Catasus L; Lagarda H; Gras E; Machin P; Prat J
Clin Cancer Res; 2000 Apr; 6(4):1598-600. PubMed ID: 10778994
[No Abstract] [Full Text] [Related]
13. PTEN mutations in endometrial carcinomas: a molecular and clinicopathologic analysis of 38 cases.
Bussaglia E; del Rio E; Matias-Guiu X; Prat J
Hum Pathol; 2000 Mar; 31(3):312-7. PubMed ID: 10746673
[TBL] [Abstract][Full Text] [Related]
14. Intragenic PTEN/MMAC1 loss of heterozygosity in conventional (clear-cell) renal cell carcinoma is associated with poor patient prognosis.
Velickovic M; Delahunt B; McIver B; Grebe SK
Mod Pathol; 2002 May; 15(5):479-85. PubMed ID: 12011252
[TBL] [Abstract][Full Text] [Related]
15. Patterns of loss of heterozygosity at 10q23.3 and microsatellite instability in endometriosis, atypical endometriosis, and ovarian carcinoma arising in association with endometriosis.
Ali-Fehmi R; Khalifeh I; Bandyopadhyay S; Lawrence WD; Silva E; Liao D; Sarkar FH; Munkarah AR
Int J Gynecol Pathol; 2006 Jul; 25(3):223-9. PubMed ID: 16810057
[TBL] [Abstract][Full Text] [Related]
16. Allelic imbalance and mutations of the PTEN gene in ovarian cancer.
Saito M; Okamoto A; Kohno T; Takakura S; Shinozaki H; Isonishi S; Yasuhara T; Yoshimura T; Ohtake Y; Ochiai K; Yokota J; Tanaka T
Int J Cancer; 2000 Jan; 85(2):160-5. PubMed ID: 10629071
[TBL] [Abstract][Full Text] [Related]
17. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies.
Tashiro H; Blazes MS; Wu R; Cho KR; Bose S; Wang SI; Li J; Parsons R; Ellenson LH
Cancer Res; 1997 Sep; 57(18):3935-40. PubMed ID: 9307275
[TBL] [Abstract][Full Text] [Related]
18. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C
Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387
[TBL] [Abstract][Full Text] [Related]
19. Analysis of PTEN and the 10q23 region in primary prostate carcinomas.
Feilotter HE; Nagai MA; Boag AH; Eng C; Mulligan LM
Oncogene; 1998 Apr; 16(13):1743-8. PubMed ID: 9582022
[TBL] [Abstract][Full Text] [Related]
20. beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas.
Moreno-Bueno G; Gamallo C; Pérez-Gallego L; de Mora JC; Suárez A; Palacios J
Diagn Mol Pathol; 2001 Jun; 10(2):116-22. PubMed ID: 11385321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]